Develops, manufactures and markets proprietary in vitro diagnostic
products and medical devices for use in clinical laboratories,
physician offices and workplace testing.
Stage of Initial
Investment:
Seed/Early
Liquidity:
Merged with Epitope, Inc. to become OraSure (Nasdaq: OSUR)
